Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|4|494-505

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.4, 2010-04, pp. : 494-505

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gut Homing Molecule Regulation of the Pathogenesis and Treatment of Inflammatory Bowel Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 14, Iss. 1, 2015-02 ,pp. : 4-12

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-01 ,pp. : 1345-1352

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 16, 2008-11 ,pp. : 1452-1467

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1508-1521

Bentham Science Publishers

Access to resources Recommend Favorite

NF-&kgr;B: a therapeutic target in inflammatory diseases

By Curran C.L.   Blackwell T.S.   Christman J.W.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 2, 2001-04 ,pp. : 197-204

Informa Healthcare

Access to resources Recommend Favorite